1. Guest, the 'News in Brief' for the week beginning 8th August 2022 is here.
    Dismiss Notice
  2. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

The effect of IL-2 stimulation and treatment of TRPM3 on channel co-localisation with PIP2 and NK cell function in ME/CFS patients 2021, Staines et al

Discussion in 'ME/CFS research' started by Sly Saint, Jul 15, 2021.

  1. Sly Saint

    Sly Saint Senior Member (Voting Rights)

    Messages:
    7,676
    Location:
    UK
    The effect of IL-2 stimulation and treatment of TRPM3 on channel co-localisation with PIP2 and NK cell function in myalgic encephalomyelitis/chronic fatigue syndrome patients

    Abstract
    Background

    Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a serious multifactorial disorder. The origin remains ambiguous, however reduced natural killer (NK) cell cytotoxicity is a consistent immunological feature of ME/CFS. Impaired transient receptor potential melastatin 3 (TRPM3), a phosphatidylinositol dependent channel, and impaired calcium mobilisation have been implicated in ME/CFS pathology. This investigation aimed to examine the localisation of TRPM3 at the NK cell plasma membrane and co-localisation with phosphatidylinositol 4,5-bisphosphate (PIP2). The effect of IL-2 priming and treatment using pregnenolone sulfate (PregS) and ononetin on TRPM3 co-localisation and NK cell cytotoxicity in ME/CFS patients and healthy controls (HC) was also investigated.

    Methods
    NK cells were isolated from 15 ME/CFS patients and 15 age- and sex-matched HC. Immunofluorescent technique was used to determine co-localisation of TRPM3 with the NK cell membrane and with PIP2 of ME/CFS patients and HC. Flow cytometry was used to determine NK cell cytotoxicity. Following IL-2 stimulation and treatment with PregS and ononetin changes in co-localisation and NK cell cytotoxicity were measured.

    Results
    Overnight treatment of NK cells with PregS and ononetin resulted in reduced co-localisation of TRPM3 with PIP2 and actin in HC. Co-localisation of TRPM3 with PIP2 in NK cells was significantly reduced in ME/CFS patients compared with HC following priming with IL-2. A significant increase in co-localisation of TRPM3 with PIP2 was reported following overnight treatment with ononetin within ME/CFS patients and between groups. Baseline NK cell cytotoxicity was significantly reduced in ME/CFS patients; however, no changes were observed following overnight incubation with IL-2, PregS and ononetin between HC and ME/CFS patients. IL-2 stimulation significantly enhanced NK cell cytotoxicity in HC and ME/CFS patients.

    Conclusion
    Significant changes in co-localisation suggest PIP2-dependent TRPM3 function may be impaired in ME/CFS patients. Stimulation of NK cells with IL-2 significantly enhanced cytotoxic function in ME/CFS patients demonstrating normal function compared with HC. A crosstalk exists between IL-2 and TRPM3 intracellular signalling pathways which are dependent on Ca2+ influx and PIP2. While IL-2R responds to IL-2 binding in vitro, Ca2+ dysregulation and impaired intracellular signalling pathways impede NK cell function in ME/CFS patients.

    https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-021-02974-4
     
  2. Tom Kindlon

    Tom Kindlon Senior Member (Voting Rights)

    Messages:
    1,760
    16-minute talk on this
    Code:
    https://www.facebook.com/NCNED/posts/pfbid0zcNi8aX96jNmz91Gn3ANSroZ48nqhkDM9Nzasjk26qUaF1V6wvwnbfREKmnB5HT7l
    National Centre for Neuroimmunology and Emerging Diseases - NCNED

    NCNED Researcher Natalie Eaton-Fitch presented her ME/CFS research findings at our ME/CFS International Conference 2021:RID last year. Natalie’s presentation was titled Effect of IL2 stimulation and treatment of TRPM3 ion channels: co-localisation with PIP2 and NK cell function in ME/CFS – please find the presentation attached.
     
    Trish likes this.

Share This Page